BARBARA TROJANIAK: Open Payments
NPI 1679927719 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 40 payments from 16 companies in 2025. Trend: 2023 $28 · 2024 $152 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $208 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Bausch Health US, LLC | 4 | $71 |
| Noven Therapeutics, LLC | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $38 |
| Almatica Pharma LLC | 2 | $37 |
Products named: VRAYLAR, APLENZIN, TRINTELLIX, Xelstrym, Auvelity, COBENFY, INGREZZA, Sunosi.
Industry payments across FL — which companies pay providers there.
